Simulations Plus (NASDAQ:SLP) Hits New 52-Week Low – Should You Sell?

Simulations Plus, Inc. (NASDAQ:SLP)’s share price hit a new 52-week low during trading on Wednesday . The stock traded as low as $29.25 and last traded at $29.52, with a volume of 19129 shares traded. The stock had previously closed at $29.75.

Analyst Ratings Changes

A number of analysts have recently issued reports on the stock. BTIG Research reduced their price target on shares of Simulations Plus from $60.00 to $50.00 and set a “buy” rating for the company in a research report on Thursday, October 24th. William Blair reissued an “outperform” rating on shares of Simulations Plus in a research note on Thursday, October 24th. KeyCorp initiated coverage on shares of Simulations Plus in a research note on Monday, July 29th. They issued an “overweight” rating and a $47.00 price target on the stock. Finally, JMP Securities began coverage on Simulations Plus in a report on Tuesday, July 16th. They set a “market perform” rating for the company. One investment analyst has rated the stock with a hold rating and five have assigned a buy rating to the stock. According to MarketBeat, Simulations Plus currently has a consensus rating of “Moderate Buy” and an average price target of $54.50.

Simulations Plus Stock Down 5.1 %

The company has a 50-day moving average price of $32.46 and a 200-day moving average price of $40.10. The company has a market capitalization of $544.67 million, a price-to-earnings ratio of 55.55 and a beta of 0.69.

Simulations Plus (NASDAQ:SLP) last posted its quarterly earnings data on Wednesday, October 23rd. The technology company reported $0.06 earnings per share for the quarter, beating the consensus estimate of $0.04 by $0.02. The company had revenue of $18.70 million during the quarter, compared to analysts’ expectations of $19.73 million. Simulations Plus had a return on equity of 6.16% and a net margin of 14.15%. Simulations Plus’s revenue for the quarter was up 19.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.18 earnings per share. Equities analysts expect that Simulations Plus, Inc. will post 1.11 EPS for the current fiscal year.

Insiders Place Their Bets

In other Simulations Plus news, Director Walter S. Woltosz sold 20,000 shares of Simulations Plus stock in a transaction on Tuesday, October 1st. The shares were sold at an average price of $31.26, for a total transaction of $625,200.00. Following the sale, the director now owns 3,481,592 shares in the company, valued at $108,834,565.92. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. In the last quarter, insiders sold 40,750 shares of company stock worth $1,352,455. 20.90% of the stock is currently owned by company insiders.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of SLP. Azzad Asset Management Inc. ADV grew its position in Simulations Plus by 3.6% during the 2nd quarter. Azzad Asset Management Inc. ADV now owns 8,007 shares of the technology company’s stock worth $389,000 after acquiring an additional 280 shares during the last quarter. InTrack Investment Management Inc increased its stake in shares of Simulations Plus by 1.1% in the second quarter. InTrack Investment Management Inc now owns 31,665 shares of the technology company’s stock valued at $1,540,000 after buying an additional 330 shares in the last quarter. Chatham Capital Group Inc. raised its holdings in shares of Simulations Plus by 1.3% in the second quarter. Chatham Capital Group Inc. now owns 34,554 shares of the technology company’s stock valued at $1,680,000 after buying an additional 450 shares during the last quarter. The Manufacturers Life Insurance Company raised its holdings in shares of Simulations Plus by 7.7% in the second quarter. The Manufacturers Life Insurance Company now owns 6,391 shares of the technology company’s stock valued at $311,000 after buying an additional 456 shares during the last quarter. Finally, Price T Rowe Associates Inc. MD lifted its position in Simulations Plus by 5.9% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 10,048 shares of the technology company’s stock worth $414,000 after buying an additional 562 shares in the last quarter. 78.08% of the stock is currently owned by institutional investors and hedge funds.

Simulations Plus Company Profile

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.